Company Filing History:
Years Active: 2010-2014
Title: Melinda Gunnell: Innovator in Immunology
Introduction
Melinda Gunnell is a prominent inventor based in Conway, Arkansas. She has made significant contributions to the field of immunology, particularly through her innovative research and patent developments. With a focus on hapten compounds and monoclonal antibodies, her work addresses critical issues related to drug recognition and immune response.
Latest Patents
Melinda Gunnell holds 2 patents that showcase her groundbreaking research. Her latest patents include "Hapten compounds and compositions and uses thereof," which relates to hapten compounds comprising either (+) methamphetamine or (+) amphetamine conjugated to a linker. This invention aims to elicit an immune response to one or more of these compounds. Another significant patent is "Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine-like compounds." This invention focuses on monoclonal antibodies that recognize at least one compound from a specific group, while not recognizing their negative counterparts.
Career Highlights
Melinda is affiliated with the University of Arkansas, where she continues to advance her research in immunology. Her work has garnered attention for its potential applications in drug recognition and therapeutic development.
Collaborations
Throughout her career, Melinda has collaborated with notable colleagues, including S. Michael Owens and F. Ivy Carroll. These partnerships have contributed to the success and impact of her research.
Conclusion
Melinda Gunnell's innovative work in the field of immunology, particularly her patents related to hapten compounds and monoclonal antibodies, highlights her significant contributions to science. Her research continues to pave the way for advancements in drug recognition and immune response.